Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2003
10/16/2003WO2003084527A1 Severe sepsis preventive therapeutic agent
10/16/2003WO2003084525A1 Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
10/16/2003WO2003084524A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
10/16/2003WO2003084521A2 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
10/16/2003WO2003084351A1 Use of creatine pyruvate for increasing stamina during highly intensive intermittent physical exertion
10/16/2003WO2003062405A3 Method for inducing differentiation of embryonic stem cells
10/16/2003WO2003062276A3 Multimers of receptor-binding ligands
10/16/2003WO2003061639A3 Use of glutathione synthesis stimulating compounds in reducing insulin resistance
10/16/2003WO2003061620A3 Peptide-carrying bodies for immune response
10/16/2003WO2003057650A3 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
10/16/2003WO2003053922A3 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
10/16/2003WO2003048772A3 Detection d'autoanticorps reactifs aux molecules antigenes d'ilots pancreatiques et/ou a l'insuline Detection of autoantibodies reactive molecules to antigens of pancreatic islets and / or insulin
10/16/2003WO2003048108A3 Compounds for treatment of inflammation, diabetes and related disorders
10/16/2003WO2003041679A3 Product containing a red alga extract of the genus porphyra and uses thereof for protecting cells
10/16/2003WO2003039231A3 Compounds and methods for treating transplant rejection
10/16/2003WO2003035835A3 Glycoprotein compositions
10/16/2003WO2003033660A3 9136, a human aldehyde dehydrogenase family member and uses therefor
10/16/2003WO2003033527A3 Cyclosporine analogue mixtures and their use as immunomodulating agents
10/16/2003WO2003032969B1 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications
10/16/2003WO2003015494A3 Tocopherol enriched compositions and amelioration of inflammatory symptoms
10/16/2003WO2003008407A3 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002090493A3 Δ4-desaturase genes and uses thereof
10/16/2003WO2002084298A3 Medicaments which are modulators of hm74 and/or hm74a activity
10/16/2003WO2002064134A3 Use of calcium indomethacin for the treatment of cyclo-oxygenase 2-mediated pathologies
10/16/2003WO2002036151A3 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
10/16/2003WO2002024307A3 Reducing the content of particular cell types in a biological sample
10/16/2003WO2002007673A3 Calcilytic compounds
10/16/2003WO2002003978A3 A COMBINATION OF FBPase INHIBITORS AND ANTIDIABETIC AGENTS USEFUL FOR THE TREATMENT OF DIABETES
10/16/2003US20030196217 Desaturase genes, enzymes encoded thereby, and uses thereof
10/16/2003US20030195361 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
10/16/2003US20030195352 For therapy of diabetes, obesity, impaired glucose tolerance, gastrointestinal disorders, hypertriglyceridemia, hypercholesteolemia, atherosclerotic disorders, or cardiovascular disorders
10/16/2003US20030195261 Administering racemic or optically pure sibutramine metabolite, or a pharmaceutically acceptable salt, solvate, or clathrate for prophylaxis or therapy
10/16/2003US20030195251 For therapy of psychiatric, pain and other disorders
10/16/2003US20030195247 Antagonists of protein tryosin phosphatase 1B (PTP-1B) and T-cell protein tyrosine phosphatase (TC-PTP), used as antidiabetic agents and for prophylaxis of insulin resistance
10/16/2003US20030195241 Mitogen-activated protein kinase inhibitors used for prophylaxis of cancer, inflammatory and cardiovascular disorders, and as coatings for medical equipments such as stents
10/16/2003US20030195238 Enzyme inhibitors
10/16/2003US20030195236 Heterocyclic imines such as 2-methyl-3-toluoyloxy-4-formyl-5-hydroxymethylpyridine, used for prophylaxis of vitamin B6 deficiency, cardiovascular disorders or melanomas
10/16/2003US20030195235 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
10/16/2003US20030195230 Substituted amine derivatives and methods of use
10/16/2003US20030195226 Nitrogen compounds such as pyridine-3-carbaldehyde, O-(((4-undecyloxy-phenyl)amino)carbonyl)oxime, used for prophylaxis of vision, eating or cardiovascular disorders, and as anxiolytic and antiemetic agents
10/16/2003US20030195222 Substituted pyrimidinones and pyrimidinthiones
10/16/2003US20030195221 Substituted indolizine-like compounds and methods of use
10/16/2003US20030195218 Treating hyperlipidemic condition, gallstones
10/16/2003US20030195216 Octahydro-2H-pyrido[1,2-a] pyrazine compounds
10/16/2003US20030195212 An amide derivatives for treating obesity, anorexia, inflammation, mental diseases associated with the melanocyte stimulating hormones
10/16/2003US20030195211 Inhibitors of human phosphatidylinositol 3-kinase delta
10/16/2003US20030195206 An enzyme inhibitors, enzyme is to catalyse the hydrolysis of an ester; treating hyperlipaemia, hyperglycaemia (type II diabetes), hypertension, cardiovascular disorders stroke, gastrointestinal disease; chemical intermediate synthesis
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195199 Pancreatic lipase inhibitor compounds, their synthesis and use
10/16/2003US20030195194 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/16/2003US20030195188 Pyridine and quinoline derivatives
10/16/2003US20030195187 For therapy of obesity or type II diabetes
10/16/2003US20030195181 Laulimalide derivatives
10/16/2003US20030195175 Use of carbon-2-modified-vitamin D analogs to induce the formation of new bone
10/16/2003US20030195172 Novel phosphonic acid compounds as inhibitors of serine proteases
10/16/2003US20030195171 Method for inhibiting bone resorption with an alendronate and vitamin D formulation
10/16/2003US20030195168 Comprises macrocyclic diterpene compounds from Euphorbiaceae for treatment and prophylaxis of protein kinase C (PKC) related conditions (alcoholism, Alzheimer's disease, asthma, atherosclerosis); expression inhibition; computer programs
10/16/2003US20030195157 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
10/16/2003US20030195154 Comprises mimetics of erythropoietin, thrombopoietin, and glucagon-like peptide conjugated to polymer
10/16/2003US20030195147 Identification of molecular structures, especially peptides, which are capable of acting at either insulin or insulin-like growth factor receptors as agonists or antagonists; treatment of diabetes
10/16/2003US20030195146 Prepared by culturing Beauveria in medium; substances thus obtained are less toxic, specifically inhibit acyl-Coenzyme A: cholesterol acyltransferase, and inhibit formation of oil droplets in macrophages
10/16/2003US20030195145 Methods of treatment with combinations of statin and aryl-substituted propanolamine derivatives
10/16/2003US20030195142 Formulated composition
10/16/2003US20030194761 Novel nucleic acid sequences encoding human fibroblast growth factor-like polypeptides
10/16/2003US20030194732 For treating neoplastic diseases by testing responsiveness to interferons
10/16/2003US20030194720 Human ion channels
10/16/2003US20030194719 Tpst-assay for diagnosis of autism and related disorders
10/16/2003US20030194478 Improved hunt or search performance of sport and task animals, such as hunting dogs and search dogs, by orally administering eicosapentaenoic acid and/or docosahexaenoic acid
10/16/2003US20030194442 Insoluble drug particle compositions with improved fasted-fed effects
10/16/2003US20030194440 Pharmaceutical composition for sustained release of the hmg-coa reductase inhibitor fluvastatin
10/16/2003US20030194413 Methods and compositions employing red rice fermentation products
10/16/2003US20030192540 Therapeutic dry powder preparation
10/16/2003US20030192226 Animal decoy
10/16/2003CA2481995A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors
10/16/2003CA2481976A1 Novel thyroid receptor ligands
10/16/2003CA2481879A1 Hydroxamic acid derivatives
10/16/2003CA2481819A1 Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
10/16/2003CA2481817A1 Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
10/16/2003CA2481706A1 Antidiabetic agents
10/16/2003CA2481701A1 Benzoxazinone-derived compounds, their preparation and use as medicaments
10/16/2003CA2481392A1 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003CA2481035A1 (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives
10/16/2003CA2481028A1 Hormone replacement therapy
10/16/2003CA2480818A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
10/16/2003CA2480697A1 Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
10/16/2003CA2480311A1 Oligomeric compounds for the modulation of hif-1alpha expression
10/16/2003CA2480082A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
10/16/2003CA2476545A1 Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
10/15/2003EP1352897A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352896A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352895A2 Adamantane derivatives for the treatment of inflammatory, immune and cardiovascular diseases
10/15/2003EP1352652A1 Fat composition for oral or enteral administration and hexacosanoic acid depressant
10/15/2003EP1352638A1 Cosmetics
10/15/2003EP1352062A2 Improved growth hormone molecules
10/15/2003EP1351985A2 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
10/15/2003EP1351983A2 Gmg-3, gmg-4, and gmg-6 polynucleotides and polypeptides and uses thereof
10/15/2003EP1351975A2 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
10/15/2003EP1351971A2 Compounds useful for treating hypertriglyceridemia
10/15/2003EP1351963A1 A process for the synthesis of atorvastatin form v and phenylboronates as intermediate compounds
1 ... 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 ... 1298